Loading...
A-
A+

Fonts Size

Change Color

Alert:

Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here


RESEARCH AND INNOVATION
CENTER

Abu Dhabi Healthcare Sector has the
potential to deliver high quality Medical
Research and Innovation

RESEARCH AND INNOVATION DASHBOARD

PRIORITIES

Department of Health has strategized key priorities that underpin the goal of improving the well-being of Abu Dhabi residents through prevention and access to integrated, innovative, high-quality and cost-effective healthcare. Genomic medicine is a ground-breaking genomics initiative that involves using genomic information about an individual to understand genetics bases, provide accurate diagnosis and treatment and implement precision medicine. A healthier Abu Dhabi community will not be achieved expediently unless innovation and research are at the core of its daily business.

Priority Disease

  • Cancer and Rare Disease
  • Cardiovascular Disease (Obesity, Diabetes, Hypertension, Smoking …etc)
  • Chronic Respiratory Disease
  • Emerging Infectious Disease & Antimicrobial Resistance
  • Injuries and Occupational Health
  • Mental Health Behavioral, and Neurodegenerative Disorders
  • Woman and Child Health (Reproductive, Maternal, Newborn, Child Health, and Developmental Diseases)

Areas of Research

  • Big Data
  • Internet of Medical Things (IOMT)
  • Precision Medicine
  • Assistive Technology
  • Drug Discovery
  • Discovery Science
  • Advanced Therapies (cell therapies, implantable devices, robotics, etc)
  • Nano-Medicine
  • Biomedicine
  • Public Health/Prevention
  • Genetic and Epigenetics

Research and Innovation
Programs

Publications

Resource

Medical Research and Development

This applies to all entities who are interested in conducting a human subject research in Abu Dhabi such as:

  • Healthcare facilities
  • Academic institutes
  • Contract Research
    Organizations (CRO’s)
  • Government/Private
    institutes

01.

Application submission

02.

Review process

03.

Final decision release

04.

Facility name will appear on the list of facilities approved to carry out human subject research

View Facilities List

Requirements

  1. Application for Authorization to Conduct Human Subjects Research
  2. Research Ethics Committee (REC) members list
    - Including CVs and DOH health license if applicable
  3. Research Ethics Training Course For all ethics committee members
  4. DOH Undertaking letter
    - Signed by all REC members

To send the forms or any inquiries, email us at medical.research@doh.gov.ae

Maximum attachment size is 8 MB

Organizations and researchers who are interested in conducting human subject research in the below streams, have to apply directly to DOH Medical Research and Development Division (DOH REC/IRB).

It is possible to apply for a research evaluation that falls within the following list of the Abu Dhabi Health Research and Technology Committee (ADHRTC) in the Department of Health.

Critical proposals listed in the criteria for human subjects research must be reviewed by the Abu Dhabi Health Research and Technology Committee (ADHRTC) are:

  • Multicenter studies.
  • Clinical trials: Phase I, II, III, and IV.
  • Any Industry (Pharmaceutical/MedTech/Human AI) studies.
  • Any research that carries significant risks to humans (patients).
  • Any research with genetic/genomics data/sample.
  • Any data or sample that will be processed outside the UAE for research purposes.

Research proposals for the above streams will be evaluated by DOH ADHRTC (Abu Dhabi Research and Technology Committee)

01.

Application Submission

Application form

02.

Review process

03.

Final Decision Release

05.

Browse the Research Registry for the researches evaluated by Abu Dhabi Health Research and Technology Committee

Research Registry

Requirements

New submission

  • Research Application form V.3 - (Information Security Exemption form, if applicable)
  • Research proposal/protocol
  • CVs and GCPs certificates of the research team Click here for guidance
  • Data collection sheet, if applicable
  • Informed consent form, if applicable
  • Survey/Questionnaire, if applicable

Renewal request

  • Initial/Original approval letter
  • Latest renewal letter
  • Study progress report
  • Exemption form & Initial research form
  • Amendment letter if the PI have been changed.
  • DSMB/DMC letter, if applicable

Amendment request

  • Amendment form (reference # to the original study approval “initial and all associated approval letters”)
  • Amendment supporting documents, if applicable
    (*Additional documents to the study is considered as an amendment and not notification.)

Pre-publication request

  • Initial Approval
  • Pre-Publication form
  • Pre-publication/Manuscript

General Notification

  • Study approval letter
  • Notification brief

*Principal Investigator and study must be affiliated in one of the authorized facilities to conduct human subject research.
*DOH related published regulatory tools: Standard on Human Subject Research. (2019). Department of Health, Guidelines for Conducting Clinical Trials with Investigational Product

For inquiries email us at : medical.research@doh.gov.ae

The Showcase of Medical Research Publications from Abu Dhabi is a collection of valuable medical research which appeared in peer-reviewed journals from healthcare community within Abu Dhabi’s healthcare sector. The Showcase includes scientific literature on a wide range of medical topics.

01.

Find out more about the medical research publications from Abu DHabi

View the publications

For any inquiries, email : medical.research@doh.gov.ae

INNOVATION SERVICES

Health technology assessment (HTA) refers to the systematic evaluation of properties, effects, and/or impacts of health technology.

01.

Submit HTA application (please find Forms and Documents below)

02.

Once received, an evaluation process will take place based on safety, efficiency and effectiveness

03.

An Official letter will be sent to applicants (Approved or Disapproved)

04.

Codes/pricing, product/therapy registration and publication

05.

Browse the Technology Registry

Technology Registry

Fill the forms and email us at adhtac@doh.gov.ae

Maximum file size is 8 MB

For disapproval decisions: HTA applicants appealing submission to adhtac@doh.gov.ae
(Within 30 days of receiving disapproval decision) to start the same journey.

Shape the future of healthcare through innovation. HealthTech Hub offers a comprehensive support network for the testing, implementation and commercialization of health technologies.

01.

Initial interview & meeting of startups

02.

Startup submission of business plan and requirements for ecosystem support

03.

Agreement of joint project plan and timeline

04.

Startups application of ADGM Tech License

05.

DoH support in regulation, Proof of Concept Design, Coaching, Access to Investor Networks, Access to Partners and Health Technology Assessment

06.

Graduation from DoH HealthTech program (maximum 24 months)

For any inquiries, email us at: HID@doh.gov.ae

Drug and Medical Products

Through this service, as drug agents and healthcare providers (hospitals), you can apply to code drugs, including conventional and general sale products. These codes are essential for drug product reimbursement by insurance and applicants can apply to amend coded drug details.

01

Submit the application and all required documents through TAMM portal

TAMM portal

02.

Receive DoH’s approval, rejection or request for additional details

03.

Obtain the drug code.

Required Documents:

  1. MOH Drug/Product Registration Certificate; From the Ministry of Health and Prevention for registered drugs (drug agents)
  2. MOH Price Certificate; From the Ministry of Health and Prevention for registered drugs (drug agents)
  3. Price Quotation; For non-registered drugs (hospitals)
  4. Good Manufacturing Practice (GMP) Certificate; For non-registered drugs (hospitals)
  5. Artwork/Product Image
  6. Product Image
  7. Product Leaflet

For any inquiries, email :  dmp@doh.gov.ae

Through this service, you can apply for laboratory analysis of any medical product, such as pharmaceuticals, dietary supplements, herbal or cosmetic products to ensure the absence of any dangerous substances and that it is safe for use.

Conditions
The applicant must hand in the sample in person.

01

Applicants to submit form and required documents through TAMM portal

TAMM portal

02.

Submit the sample of the product At the Department of Health counter

03.

Obtain the results from DoH through SMS or a phone call, if needed

Call 800555 (Abu Dhabi Government Portal)

Through this service, healthcare facilities in Abu Dhabi may apply to assign or replace a person that is responsible for narcotics and controlled drugs

01

Applicants to submit form and required documents through TAMM portal

TAMM portal

02.

Once received, an evaluation process will take place

03.

Receive the approved electronic application form

Required Documents:

  1. Application Form; Complete and sign the “Approving a person to be responsible for narcotics and controlled drugs” form
  2. Official Letter From the Medical Director to authorize the current person in-charge
  3. Signed handover Report on Controlled and Narcotic Drugs; in case of changing responsible person

For any inquiries, email :  dmp@doh.gov.ae

Through this service, Facility’s Narcotic in-charge should submit the consumption report for controlled drugs on a monthly basis and quarterly for narcotic drugs.

Process and required documents:

01

Click here to download the report form.

Download Now

02.

Send the monthly controlled report to DoH through

cdreport@doh.gov.ae

03.

Send the Narcotic quaterly report to DoH through

narcoticreport@doh.gov.ae

For any inquiries, email : cdreport@doh.gov.ae

Through this service, Facility’s Narcotic in charge should report to DoH any lost/broken ampoules; or any narcotic or controlled drugs incidences.

01

Download the Narcotic/ Controlled Drug Incident Report Form.

Download Now

02.

Enclose and submit the required documents as required.

03.

Send the form to DoH Narcotic officer through e-mail address:

dmp@doh.gov.ae

Through this service you can access the unified electronic platform approved at the country level for prescribing and dispensing of narcotic, controlled and semi controlled medicines.

The federal law obligates all healthcare facilities and providers to use the system for prescribing and dispensing narcotic, controlled and semi-controlled medicines. Also, all licensed healthcare facilities and pharmacies must provide Emirates ID card reader to all their physicians and pharmacists who are dealing with narcotic and controlled medicines.

Register the health facility on the Electronic Platform for Controlled Medicines, or log-in the platform if the facility is registered, as mentioned in the links below.

01

New user - register on the Electronic Platform for Controlled Medicines

Register Now

02.

Existing user - log in to the platform

Log-In

03.

For more information or technical support, please contact: Tel. 600566635 Email: NPCM.support@tahaluf.ae

Download Relevant Circular

Through this service, concerned stakeholders including hospitals, pharmacies and drug suppliers are required to report all anticipated and /or actual drug shortages to DOH immediately in order to avert and mitigate the problem.

Process:

01

Download the Drug Shortage Reporting Form.

Download Now

02.

Send the Reporting Form through e-mail address

dmp@doh.gov.ae

03.

Receive the approved electronic application form

DoH will work closely with the drug suppliers, manufacturers & health care facilities to identify root causes of the reported shortages and fill any gaps in the supply chain to ensure ease of access and availability of necessary medicines to all residents of Abu Dhabi.

Through this service, healthcare professionals can report any suspected Adverse Reaction (AR), Medication Error (ME) and Adverse Event Following Immunization (AEFI) experienced from any of the drug product within the stipulated timeframe as defined in DoH policies, even if reporters are not certain that the particular medicinal product was the cause. Unintended adverse effects, drug abuse, overdose, interaction (including drug-drug and drug-food interactions) and unusual lack of therapeutic efficacy are all considered to be reportable suspected Adverse Reactions (AR).

01

Click the button below to access the e-Notification system

E-Notification

02.

Log in using your professional or facility account information

03.

Select notification then Pharmacovigilance then select type of report

Download Now

04.

Fill out all the required information

05.

Click ‘’Submit “

For any enquiries send an email to:  pve@doh.gov.ae

Through this service Healthcare facilities are required to submit their antidote stock report on monthly basis . The service allows the hospital user to report the stock of antidote by the 5th of each month.

Process:

01

Click the here to access the e-Notification system.

E-Notification

02.

Log in using your professional or facility account information.

03.

Select notification then Antidote Monthly Stock Report.

04.

The Antidote Monthly Stock Report Form will be displayed to be filled by user.

For enquiries e-mail to  PVE@doh.gov.ae

Subscribe for updates

Thanks for Subscribing

Last updated: 09 Dec 2024

Mobile For an optimal experience please
rotate your device to portrait mode